Management of acute, severe asthma in children

Annals of Pharmacotherapy

Volumn 36, Issue 7-8, 2002, Pages 1249-1260

  Streetman, Darcie D ^a   Bhatt Mehta, Varsha ^a   Johnson, Cary E ^a   Perez, Annette ^a   Paquette Lamontagne, Nicolas ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Acute asthma; Anticholinergics; Heliox; Magnesium; Theophylline; 2 adrenergic agonists

Indexed keywords

AMINOPHYLLINE; ANTIASTHMATIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; FLUTICASONE; HELIOX; IPRATROPIUM BROMIDE; ISOPRENALINE; LEVALBUTEROL; MAGNESIUM; METHYLPREDNISOLONE; MONTELUKAST; PREDNISOLONE; PREDNISONE; SALBUTAMOL; TERBUTALINE; THEOPHYLLINE; BRONCHODILATING AGENT; CORTICOSTEROID;

ACUTE DISEASE; ALGORITHM; ARTICLE; ASTHMA; CHILD CARE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERGLYCEMIA; HYPOKALEMIA; MEDLINE; METERED DOSE INHALER; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; TACHYCARDIA; TREMOR; WHEEZING; XEROSTOMIA; CHILD; CONTROLLED CLINICAL TRIAL; EMERGENCY HEALTH SERVICE; RANDOMIZED CONTROLLED TRIAL; REVIEW; STATISTICS; TREATMENT OUTCOME;

ACUTE DISEASE; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ALBUTEROL; ASTHMA; BRONCHODILATOR AGENTS; CHILD; EMERGENCY SERVICE, HOSPITAL; HUMANS; IPRATROPIUM; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME;

EID: 0036020168     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A189     Document Type: Article

References (68)

1. Changing patterns of asthma hospitalizations among children: 1979 To 1987
2. Surveillance for asthma - United States, 1960-1995
3. Measuring childhood asthma prevalence before and after the 1997 redesign of the National Health Interview Survey
4. Decreases in asthma mortality in the United States
5. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma
6. Pathophysiology of allergic inflammation
7. Asthma
8. Ultrastructural examination of bronchial biopsy specimens from children with moderate asthma
9. Beta-adrenergic agonists for acute, severe asthma
10. A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children
11. Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma
12. The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients
13. Dose-response evaluation of levalbuterol versus racemic albuterol in patients with asthma
14. Effect of nebulized ipratropium on the hospitalization rates of children with asthma
15. Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma
16. Randomized controlled trial of ipratropium bromide and frequent low doses of salbutamol in the management of mild and moderate acute pediatric asthma
17. Ipratropium bromide added to asthma treatment in the pediatric emergency department
18. Effectiveness of steroid therapy in acute exacerbations of asthma: A meta-analysis
19. Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma
20. Effect of a short course of prednisone in the prevention of early relapse after the emergency room treatment of acute asthma
21. Are intravenous corticosteroids required in status asthmaticus?
22. Intravenous versus oral corticosteroids in the management of acute asthma in children
23. Intravenous magnesium therapy for moderate to severe pediatric asthma: Results of a randomized, placebo-controlled trial
24. Higher-dose intravenous magnesium therapy for children with moderate to severe acute asthma
25. Aminophylline therapy does not improve outcome and increases adverse effects in children hospitalized with acute asthmatic exacerbations
26. Efficacy of aminophylline in the treatment of acute asthma exacerbation in children
27. Randomized controlled trial of aminophylline for severe acute asthma
28. Efficacy of IV theophylline in children with severe status asthmaticus
29. 2-agonists in the management of asthma
30. Catecholamines, sympathetic drugs, and adrenergic receptor antagonists
31. Delivery of albuterol in a pediatric emergency department
32. Is nebulized aerosol treatment necessary in the pediatric emergency department?
33. Randomized trial of salbutamol via metered-dose inhaler with spacer versus nebulizer for acute wheezing in children less than 2 years of age
34. Cost and effectiveness of spacer versus nebulizer in young children with moderate and severe acute asthma
35. Holding chambers versus nebulisers for beta-agonist treatment of acute asthma (Cochrane review)
36. Low-dose β-agonist continuous nebulization therapy for status asthmaticus in children
37. Safety of continuous nebulized albuterol for bronchospasm in infants and children
38. Continuous versus intermittent albuterol nebulization in the treatment of acute asthma
39. Comparison of intermittent and continuously nebulized albuterol for treatment of asthma in an urban emergency department
40. Levalbuterol hydrochloride
41. The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patients
42. Double-blind evaluation of methylprednisolone versus placebo for acute asthma episodes
43. Methylprednisolone therapy for acute asthma in infants and toddlers: A controlled clinical trial
44. A double-blind trial of corticosteroid therapy in status asthmaticus
45. Nebulized dexamethasone versus oral prednisone in the emergency treatment of asthmatic children
46. A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma
47. Pharmacology and toxicology of Atrovent
48. Muscarinic receptor agonists and antagonists
49. Efficacy of nebulized ipratropium in severely asthmatic children
50. 2 agonists for treating acute childhood and adolescent asthma? A systematic review
51. Bronchodilating effect of intravenous magnesium sulfate in bronchial asthma
52. Magnesium and its therapeutic uses: A review
53. Effect of magnesium chloride on rabbit bronchial smooth muscle
54. Safety and efficacy of magnesium sulfate infusion in children with status asthmaticus
55. Intravenous magnesium for acute asthma: Failure to decrease emergency treatment duration or need for hospitalization
56. Magnesium bolus or infusion fails to improve expiratory flow in acute asthma exacerbations
57. Intravenous magnesium sulfate in acute severe asthma not responding to conventional therapy
58. The therapeutic gases
59. Oxygenation in status asthmaticus improved during ventilation with helium-oxygen
60. Inhaled helium-oxygen revisited; effect of inhaled helium-oxygen during the treatment of status asthmaticus in children
61. Heliox therapy in acute severe asthma
62. The effect of heliox in acute severe asthma
63. 1 in acute asthma patients
64. Evaluation of heliox in children hospitalized with acute severe asthma
65. Montelukast for chronic asthma in 6 14-year-old children; a randomized, double-blind trial
66. Montelukast, a once daily leukotriene receptor antagonist, in the treatment of chronic asthma. A multicenter, randomized, double-blind trial
67. Comparison of the effects of intravenous and oral montelukast on airway function; a double-blind, placebo controlled, three period, crossover study in asthmatic patients